Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Yang Soon

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 27, 2022
Is there any survival benefit from post-operative radiation in brain metastases? A systematic review and meta-analysis of randomized controlled trialsNagarjun Bolem, Yu Yang Soon, Sreyes Ravi, et al.
Brain Tumor Pathology|July 1, 2020
Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 casesWanwan Chen, Yu Yang Soon, Patricia Diana Pratiseyo, et al.
Plos One|June 20, 2019
Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysisChia Ching Lee, Yu Yang Soon, Char Loo Tan, et al.
Oncotarget|April 28, 2017
Palliative radiotherapy for gastric cancer: a systematic review and meta-analysisJeremy Tey, Yu Yang Soon, Wee Yao Koh, et al.
Blood Neoplasia|June 24, 2025
Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myelomaEunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, et al.
Asia-Pacific Journal of Clinical Oncology|July 24, 2019
Clinical outcomes of external beam radiotherapy in patients with localized prostate cancer: Does dose escalation matter?Chia Ching Lee, Keith Hc Lim, David Wt Chia, et al.
JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.
Transplantation and Cellular Therapy|June 9, 2026
Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regressionAinsley Ryan Yan Bin Lee, Hon Jen Wong, Chi Ching Lim, et al.
BMJ Open|February 8, 2022
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysisShuting Han, Qingyuan Zhuang, Jianbang Chiang, et al.
International Journal of Cancer|September 25, 2021
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsYiqing Huang, Yu Yang Soon, Folefac Aminkeng, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 27, 2022
Is there any survival benefit from post-operative radiation in brain metastases? A systematic review and meta-analysis of randomized controlled trialsNagarjun Bolem, Yu Yang Soon, Sreyes Ravi, et al.
Brain Tumor Pathology|July 1, 2020
Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 casesWanwan Chen, Yu Yang Soon, Patricia Diana Pratiseyo, et al.
Plos One|June 20, 2019
Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysisChia Ching Lee, Yu Yang Soon, Char Loo Tan, et al.
Oncotarget|April 28, 2017
Palliative radiotherapy for gastric cancer: a systematic review and meta-analysisJeremy Tey, Yu Yang Soon, Wee Yao Koh, et al.
Blood Neoplasia|June 24, 2025
Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myelomaEunice Lai, Yu Yang Soon, Ainsley Ryan Yan Bin Lee, et al.
Asia-Pacific Journal of Clinical Oncology|July 24, 2019
Clinical outcomes of external beam radiotherapy in patients with localized prostate cancer: Does dose escalation matter?Chia Ching Lee, Keith Hc Lim, David Wt Chia, et al.
JNCI Cancer Spectrum|June 2, 2025
INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner's curseYu Yang Soon, Katrin Sjoquist, Ian C Marschner, et al.
Transplantation and Cellular Therapy|June 9, 2026
Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regressionAinsley Ryan Yan Bin Lee, Hon Jen Wong, Chi Ching Lim, et al.
BMJ Open|February 8, 2022
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysisShuting Han, Qingyuan Zhuang, Jianbang Chiang, et al.
International Journal of Cancer|September 25, 2021
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patientsYiqing Huang, Yu Yang Soon, Folefac Aminkeng, et al.
Pageof 8